Waters Corporation, one of the leading players in the bio-tech market, recently announced the acquisition of
Halo Labs to expand its biological analysis portfolio. It also bought
Optofluidics, Inc. Additionally, during one of its latest earnings call, it touted strong instrument sales and raised its guidance. The healthcare sector player also saw its
stock surge due to positive financial performance and was rated as a lucrative investment option. However, there were concerns of overvaluation after a rapid stock price run. Its quarterly and annual earnings were met with mixed reviews, with quarterly revenue guidance significantly missing expectations. Meanwhile, executives from the company visited Wall Street. They also attended the
Jefferies Global Healthcare Conference, discussing the growth goals for 2025. The company's business in India witnessed a boost due to a rise in weight-loss drugs. Waters Corp also opened a state-of-the-art precision manufacturing facility in
Longbridge, UK and a new global capability center in
Bengaluru, India. Additionally, Waters won inclusion in the Dow Jones Sustainability Index for the fourth consecutive year.
Waters Corp WAT News Analytics from Wed, 17 Apr 2019 16:46:00 GMT to Sat, 24 May 2025 00:20:14 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor 2
